Endothelial function analysis and atherosclerotic risk factors in adolescents with systemic lupus erythematosus

International Journal of Adolescent Medicine and Health

Volumn 19, Issue 4, 2007, Pages 497-505

  Nascif, Ana Karina Soares ^a   Hilário, Maria Odete Esteves ^a,b   Terreri, Maria Teresa Ramos Ascensão ^a   Ajzen, Sérgio Aron ^a   D'Almeida, Vánia ^a   Plavnik, Frida Liane ^a   de Jesus Christofalo, Dejaldo Marcos ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Department of Pediatrics   (Brazil)

Author keywords

Adolescence; Atherosclerosis; Endothelial function; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CHLOROQUINE; CHOLESTEROL; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FOLIC ACID; GLUCOSE; GLYCERYL TRINITRATE; HOMOCYSTEINE; LUPUS ANTICOAGULANT; METHOTREXATE; PREDNISONE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD VESSEL DIAMETER; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DYSLIPIDEMIA; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPEREMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MALE; MEDICAL ASSESSMENT; MORBIDITY; MORTALITY; REST; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 39549087290     PISSN: 03340139     EISSN: None     Source Type: Journal    
DOI: 10.1515/IJAMH.2007.19.4.497     Document Type: Article

References (26)

1. Lockshin MD, Salmon JE, Roman MJ. Atherosclerosis and lupus: a work in progress. Arthritis Rheum 2001;44: 2215-7.
2. Bruce IN, Urowitz MB, Gladman DD, Ibanez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum 2003;48:3159-67.
3. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R et al. T raditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44:2331-7.
4. Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996; 348:1120-4.
5. Tam LS, Fan B, Li EK, Thomas GN, Yim SF, Haines CJ et al. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia. J Rheumatol 2003;30:1479-84.
6. McLenachan JM, Williams JK, Fish RD, Ganz P, Selwyn AP. Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation 1991;84:1273-8.
7. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
8. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39: 257-65.
9. Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002;29:292-7.
10. Soep JB, Mietus-Snyder M, Malloy MJ, Witztum JL, von Scheven E. Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus. Arthritis Rheum 2004;51:451-7.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
12. Bombardier C, Glad man DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
13. Glad man DD, Goldsmith CH, Urowitz MB, Bacon P, Fortin P, Ginzler E et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage index for systemic lupus erythematosus international comparison. J Rheumatol 2000;27:373-6.
14. Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995;92:3431-5.
15. American Academy of Pediatrics. National cholesterol education program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89: 525-84.
16. Pierrat A, Gravier E, Saunders C, Caira MV, Ait-Djafer Z, Legras B et al. Predicting GFR in children and adults: a comparison of the Cockcroft-Gault, Schwartz, and modification of diet in renal disease formulas. Kidney Int 2003;64:1425-36.
17. Wong RC. Australasian aCL Working Party. Consensus guidelines for anticardiolipin antibody testing. Thromb Res 2004;114:559-71.
18. Moore GW, Savidge GF, Smith MP. Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time. Blood Coagul Fibrinolysis 2000;11:767-74.
19. Pfeiffer CM, Huff DL, Gunter EW. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a laboratory setting. Clin Chem 1999;45:290-2.
20. de Jongh S, Lilien MR, Bakker HD, Hutten BA, Kastelein JJ, Stroes ES. Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. Atherosclerosis 2002;163:193-7.
21. Deng YB, Li TL, Xiang HJ, Chang Q, Li CL. Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J 2003;22:34-9.
22. Kurotobi S, Kawakami N, Honda A, Matsuoka T, Hara T, Nagai T et al. Impaired vascular endothelium-dependent relaxation in Henoch-Schonlein purpura. Pediatr Nephrol 2004;19:138-43.
23. Ilowite NT, Samuel P, Ginzler E, Jacobson MS. Dyslipoproteinemia in pediatric systemic lupus erythematosus. Arthritis Rheum 1988;31:859-63.
24. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406.
25. Jarvisalo MJ, Ronnemaa T, Volanen I, Kaitosaari T, Kallio K, Hartiala JJ et al. Brachial artery dilatation responses in healthy children and adolescents. Am J Physiol Heart Circ Physiol 2002;282:H87-92.
26. Tawakol A, Omland T, Gerhard M, Creager MA. Hyperhomocysteinemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997;95:1119-21.